摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-苯甲酰基-S-甲基异硫脲 | 25508-17-2

中文名称
N-苯甲酰基-S-甲基异硫脲
中文别名
——
英文名称
N-Benzoyl-S-methyl-isothioharnstoff
英文别名
methyl N-benzoylcarbamimidothioate
N-苯甲酰基-S-甲基异硫脲化学式
CAS
25508-17-2
化学式
C9H10N2OS
mdl
——
分子量
194.257
InChiKey
WIKMCIXLAMJFBC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    13
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.11
  • 拓扑面积:
    80.8
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:6a7a32aa37bf31478d0a359cc16a8800
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    1,5-二芳基-3-氨基-1,2,4-三唑的区域选择性微波合成和衍生及其胆碱酯酶抑制特性研究†
    摘要:
    在这里,我们描述了一种有效的一锅区域选择性合成方案的开发,以从N-酰基-N - Boc-硫代氨基甲酸酯获得N-保护或N-去保护的 1,5-二芳基-3-氨基-1,2,4-三唑. 这种使用微波辐射和低反应时间(最多 1 小时)的改进方案提供了所需的化合物,产率从 50% 到 84% 不等。这种化学方法可用于具有电子不同取代基的各种芳族基团。氨基的设计和正确衍生导致化合物能够以良好的 IC 50抑制胆碱酯酶高达 1 μM。此外,通过动力学和分子模型评估描述了该系列化合物的作用方式(混合型)和SAR分析,显示了该类化合物作为这种生物活性的新支架的潜力。
    DOI:
    10.1039/c9ra04105b
  • 作为产物:
    参考文献:
    名称:
    Wheeler; Merriam, Journal of the American Chemical Society, 1901, vol. 23, p. 298
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Solution-Phase, parallel synthesis and pharmacological evaluation of acylguanidine derivatives as potential sodium channel blockers
    作者:Seetharamaiyer Padmanabhan、Ruth C Lavin、Paresh M Thakker、Jinqing Guo、Lu Zhang、Deke Moore、Michael E Perlman、Cassandra Kirk、Deborah Daly、Kathy J Burke-Howie、Teresa Wolcott、Suchitra Chari、David Berlove、James B Fischer、William F Holt、Graham J Durant、Robert N McBurney
    DOI:10.1016/s0960-894x(01)00644-8
    日期:2001.12
    Solution-phase synthesis of various acylguanidine derivatives and the evaluation of a small library of compounds as potential sodium channel blockers are described.
    描述了各种酰基胍衍生物的溶液相合成和作为潜在的钠通道阻滞剂的化合物小文库的评估。
  • A GENERAL PROCEDURE FOR THE SYNTHESIS OF ACYLGUANIDINES DERIVED FROM ALIPHATIC AND AROMATIC AMINES
    作者:Seetharamaiyer Padmanabhan、Ruth C. Lavin、Paresh M. Thakkar、Graham J. Durant
    DOI:10.1081/scc-100105128
    日期:2001.1
    Condensation of aliphatic and aromatic amines with 1-aroyl- S-methylisothiourea in the presence of triethylamine affords acylguanidines in moderate to good yields. An improved procedure for the generation of 1-aroyl-S-methylisothiourea derivatives is described.
    在三乙胺的存在下,脂肪族和芳香族胺与 1-芳酰基-S-甲基异硫脲的缩合得到中等至良好产率的酰基胍。描述了一种用于生成 1-芳酰基-S-甲基异硫脲衍生物的改进程序。
  • Antibiotic for methicillin resistant bacteria
    申请人:Research Corporation Technologies, Inc.
    公开号:US06110925A1
    公开(公告)日:2000-08-29
    The present invention is directed to anti-bacterial and anti-tumor agents and the synthesis thereof.
    本发明涉及抗菌和抗肿瘤剂及其合成。
  • Substituted guanidinedicarbonyl derivatives
    申请人:American Cyanamid Company
    公开号:US04977189A1
    公开(公告)日:1990-12-11
    This disclosure describes novel substituted guanidinedicarbonyl derivatives which possess anxiolytic activity and are also useful as agents for the treatment of cognitive and related neural behavioral problems in mammals.
    本披露描述了一种新型的取代基胍二羧酸衍生物,具有抗焦虑活性,并且也可用作哺乳动物认知和相关神经行为问题的治疗剂。
  • Risk-resistance adaptation model for caregivers and their children with sickle cell syndromes
    作者:Ronald T. Brown、Richard Lambert、Danielle Devine、Kevin Baldwin、Robert Casey、Karla Doepke、Carolyn E. Ievers、Lewis Hsu、Iris Buchanan、James Eckman
    DOI:10.1007/bf02895780
    日期:2000.6
    This investigation examined the risk-resistance adaptation model for children with sickle cell disease and their primary caregivers. Participants were 55 children, ranging in age from 5 to 16 years with a mean age of 9 years 2 months, diagnosed with sickle cell disease and their primary caregivers, recruited from a university medical center Measures included adjustment (i.e. primary caregiver and child adjustment), risk factors (i.e. disease and disability, functional independence, and psychosocial stressors), resistance factors (i.e, intrapersonal health locus of control, social-ecological), and stress processing (coping). Primary caregivers' adjustment was associated with developmental coping, R-change(2) = .08, and child adaptation was associated with an internal health locus of control, R-change(2) = .22. An indirect effect of primary caregivers' coping on child adjustment was found through influence on primary caregivers' adjustment, R-change(2) = .11. The findings support research among other chronically ill populations that suggests an association between coping and disease adjustment. The results were interpreted to support the use of theoretically driven models in predicting the adaptation of children with chronic illness and adjustment in their caregivers.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐